EP3326932A1 - Closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products - Google Patents

Closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products Download PDF

Info

Publication number
EP3326932A1
EP3326932A1 EP17194211.3A EP17194211A EP3326932A1 EP 3326932 A1 EP3326932 A1 EP 3326932A1 EP 17194211 A EP17194211 A EP 17194211A EP 3326932 A1 EP3326932 A1 EP 3326932A1
Authority
EP
European Patent Office
Prior art keywords
capsule
closure system
inner capsule
bottle
closure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17194211.3A
Other languages
German (de)
French (fr)
Other versions
EP3326932B1 (en
Inventor
Marco Maria Carlo RIZZARDI
Giuseppe ADDABBO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsulit SpA
Original Assignee
Capsulit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsulit SpA filed Critical Capsulit SpA
Publication of EP3326932A1 publication Critical patent/EP3326932A1/en
Application granted granted Critical
Publication of EP3326932B1 publication Critical patent/EP3326932B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/002Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means

Definitions

  • the present invention relates to a closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products.
  • Bottles or vials containing pharmaceutical products such as lyophilized or liquid products for injection or perfusion are generally closed by means of a perforable rubber plug, for example by means of a needle, held on the neck of the bottle by means of an aluminium capsule that completely covers the rubber plug.
  • the aluminium capsules generally have a portion that may be removed by tearing, which allows access to the rubber plug.
  • aluminium capsules consists in the fact that the steps of mounting the capsule on the rubber plug and on the neck of the bottle cannot be executed in conditions of sterilisation and the absence of undesired particles because the folding and cutting operations of the aluminium sheets for making the capsules and the mounting thereof on the mouth of the bottle involve the generation of aluminium powders which are incompatible with the conditions of sterilisation and the absence of undesired particles required for the type of products contained in the bottle itself.
  • Such aluminium capsules make it therefore difficult to minimise the level of particle contamination admitted into controlled-atmosphere environments, such as a cleanroom.
  • capsules made of plastic often are not capable of supporting the temperatures that can be reached in autoclave sterilisation processes, which may reach up to 140°C, or in any case they undergo deformations such as to put at risk the sterilisation conditions of the bottle itself.
  • the plastic capsules In order to resist the sterilisation processes, the plastic capsules must have more rigid structures that require a significant force of application in order to be mounted securely on the neck of the bottle, which force of application cannot generally be obtained with normal capsuling machines.
  • the implementation of capsuling machines with increased force of application results in a significant increase of the set-up costs of the processing plant. Moreover, the use of an increased force could result in problems of the bottles or the capsules themselves breaking.
  • Plastic capsules are also known that have several and numerous components mutually assembled with one another in various operations which however, on the one hand do not ensure an adequate resistance to the autoclave sterilisation, and on the other hand, result in an apparent increase of the production and assembly times and costs of the capsule itself.
  • the closure system for bottles containing lyophilized or liquid products particularly injectable or perfusable pharmaceutical products, indicated as a whole with reference number 1, comprises:
  • the outer capsule 15 is made in a single body and comprises an upper disc-shaped portion 17 configured to close the opening 13 of the inner capsule 9 and a lower portion 19 able to be fitted around the inner capsule 9. Moreover, according to the invention, the outer capsule 15 comprises a breaking line 21 between the upper disc-shaped portion 17 and the lower portion 19.
  • the outer capsule 15 closes and covers the inner capsule 9 both at the top and at the sides.
  • the inner capsule 9 comprises, on its lateral surface, a plurality of through-openings 33.
  • the lower portion 19 of the outer capsule 15 is fitted around the inner capsule 9, and preferably is fitted around the inner capsule 9 so as to completely cover the side thereof, and in particular the lateral through-openings 33.
  • the outer capsule 15 is fitted around the inner capsule 9 with interference so that the outer capsule 15 and the inner capsule 9 define a single body capable of giving resistance to the forces that develop, for example during the autoclave sterilisation.
  • the outer capsule 15 is made of a material of the plastic type through injection moulding.
  • the outer capsule 15 is made of a material of the polypropylene type.
  • the breaking line 21 comprises a plurality of bridges 23 made through the aforesaid injection moulding.
  • the outer capsule 15 may be made in a single injection moulding step together also with the bridges 23.
  • the breaking line 21 may comprise a weakened line defined by an incision, or partial cut, of the outer capsule 15 executed in a step successive to the one of the injection moulding of the outer capsule 15 itself.
  • the breaking line 21 allows easily separating the upper disc-shaped portion 17 of the outer capsule 15 from the lower portion 19 fitted around the inner capsule 9. This allows exposing the opening 13 of the inner capsule 9 and allows the access and perforation, for example by means of a needle, of the closure body 3.
  • the lower portion 19 of the outer capsule 15 may comprise, substantially at the breaking line 21, a band 25 having a radial thickness substantially less than the radial thickness of the remaining part of the lower portion 19.
  • the lower portion 19 of the outer capsule 15 comprises, substantially at the breaking line 21, a band 25 having a radial thickness that narrows in the axial direction 27 of approach to the breaking line 21.
  • the reduction of the thickness of the wall of the outer capsule 15 at the breaking line 21 further facilitates the separation of the upper disc-shaped portion 17 from the lower portion 19.
  • the upper disc-shaped portion 17 may be raised upwards and pulled off from the lower portion 19 by acting with the fingertip on the lower perimeter edge 24 of the upper disc-shaped portion 17 itself, which edge 24 is exposed with respect to the lateral wall of the lower portion 19, due to the narrowing of the thickness thereof approaching the breaking line 21.
  • breaking line 21 were defined by a plurality of bridges 23, the rotation of the upper disc-shaped portion 17 with respect to the central axis 27 would produce the same separating effect of the upper disc-shaped portion 17 with respect to the lower portion 19 because it would cause the breaking of the bridges 23 themselves.
  • the inner capsule 9 comprises a plurality of elastically deformable tabs 29 projecting radially towards the inside of the inner capsule 9 itself. Such tabs 29 are configured to engage with the finish 31 of the bottle 7.
  • the tabs 29 are obtained at the through-openings 33 on the lateral surface of the inner capsule 9.
  • the tabs 29 are preferably equally distributed angularly around the central axis 27.
  • the inner capsule 9 is made of a material of the plastic type, and preferably of the polycarbonate type, through injection moulding.
  • the through-openings 33 obtained at the tabs 29 allow facilitating the removal of the tabs 29 themselves from the injection mould.
  • the tabs 29 allow the inner capsule 9 to hold the closure body 3 in a sealed closure configuration against the mouth 5 of the bottle 7.
  • the tabs 29 are elastically deformable, also due to the presence of the through-openings 33, allows easily fitting the inner capsule 9 on the neck 11 of the bottle 7. Indeed, in step of pressure applying the inner capsule 9 onto the neck 11 of the bottle 7, the finish 31 exerts a force in horizontal direction on the tabs 29 themselves, which force deforms the tabs 29 radially outwards until they exceed the finish 31. Once they have exceeded the finish 31, the tabs 29 may return to their rest configuration projecting radially towards the inside of the inner capsule 9, in which configuration they engage at the bottom with the finish 31 of the bottle 7.
  • the portion of cylindrical wall 54 of the inner capsule 9 which lies at the bottom of the tabs 29 has an increased cross-section with respect to the cross-section of the overlying tabs 29.
  • the resistance is ensured to the forces which develop during the autoclave sterilisation.
  • the tabs 29 project radially towards the inside of the inner capsule 9 itself with an inclination which is less than or equal 30° with respect to the underlying portion of cylindrical wall 54, that is with respect to the vertical direction.
  • the closure body 3 may be a rubber gasket 30, as shown in figures 4 and 9 , or a rubber plug 32 as shown in figures 5 and 10 .
  • the rubber gasket 30 and the rubber plug 32 are advantageously held at the top against the mouth 5 of the bottle 7 by the inner capsule 9.
  • the rubber plug 32 also has a lower portion which is inserted, with interference, into the mouth 5 of the bottle 7.
  • the tabs 29 are adapted to hold the closure body 3 on the mouth 5 of the bottle 7, thus ensuring the seal of the liquid contained inside the bottle 7, also under the action of the internal pressure generated during the autoclave sterilisation treatment.
  • the lower portion 19 of the outer capsule 15 comprises at least one rib 35 projecting radially towards the inside of the outer capsule 15, configured to engage in a corresponding seat 37 obtained on the outer surface of the inner capsule 9.
  • At least two ribs 35 and two corresponding seats 37 are provided at least two ribs 35 and two corresponding seats 37.
  • the ribs 35 develop circumferentially around the whole lower portion 19 of the outer capsule 15, like the corresponding seats 37 develop circumferentially around the whole outer surface of the inner capsule 9.
  • the inner capsule 9 may comprise a rib 45 projecting radially towards the inside of the capsule configured to hold, by interference, the closure body 3.
  • rib 45 develops circumferentially around the whole inner capsule 9.
  • the outer capsule 15, inner capsule 9 and closure body 3 assembly define an assembly that can be handled as though it were a single body.
  • the disc-shaped upper portion 17 may comprise, at its face that faces the opening 13 of the inner capsule 9, a cylindrical wall 41 axially protruding towards the edge 39 of the opening 13 and configured to engage with such edge 39.
  • the cylindrical wall 41 ensures the centring of the disc-shaped upper portion 17 of the outer capsule 15 with respect to the edge 39 of the opening 13.
  • the disc-shaped upper portion 17 of the outer capsule 15 may comprise, at its face facing the opening 13 of the inner capsule 9, a plurality of tabs 38 axially projecting towards the edge 39 of the opening 13 and configured to engage with such edge 39.
  • the tabs 38 are also folded around the edge 39 of the opening 13, for example in assembly step between the outer capsule 15 and the inner capsule 9.
  • such coupling provides the upper disc-shaped portion 17 with increased resistance to the internal pressure that is generated in vertical direction in the bottle 7, and therefore increased resistance to the push that acts on the closure body 3 during the autoclave sterilisation treatment.
  • the closure system 1 comprises a tamper-evident ring 43 associated with the outer capsule 15.
  • the tamper-evident ring 43 is advantageously associated with the lower edge of the outer capsule 15 by means of a plurality of bridges 49.
  • the tamper-evident ring 43 comprises advantageously an undercut 51 configured to engage with the lower edge 53 of the inner capsule 9.
  • the tamper-evident ring 43 serves the purposes of emphasizing any attempts to tamper with the closure system 1.
  • the operator When the bottle 7 is used, the operator, or patient, lifts the edge 24 of the upper disc-shaped portion 17 of the outer capsule 15 with his/her fingertip, thus breaking any bridges 23 that join such upper portion to the lower portion 19 and removing the tabs 38, or the circular wall 41, from the edge 39 of the opening 13 of the inner capsule 9.
  • the opening 13 of the inner capsule 9 is exposed and it is possible to perforate the closure body 3 with a needle at the opening 13 of the inner capsule 9 to introduce it into the mouth 5 of the bottle 7 in order to suck the liquid contained in the bottle 7.
  • the closure system object of the present invention has the advantage of being made completely of a material of the plastic type and of being pressure applied onto the bottles, without generating powders that are incompatible with the sterility requirements of the product contained in the bottle itself, as instead happens in the case of closure systems at least partially made of aluminium.
  • Another advantage of the invention consists in the fact that the outer capsule, inner capsule and closure body assembly may be applied as though they were a single body, in a single step, to the bottle, directly in the cleanroom, immediately after the filling of the bottle with the product required.
  • the application of the aforesaid assembly may also be executed in completely automated manner.
  • Another advantage again of the invention consists in the fact that the tabs on the inner capsule on the one hand, allow the closure system to resist in a satisfactory manner to the stresses generated during the autoclave sterilisation process, and on the other hand, to be easily pressure applied to the neck of the bottle.
  • a further advantage of the closure system according to the invention consists in the fact of being made in a minimum number of pieces that are easy to assemble with one another, that is rubber outer capsule, inner capsule and closure body.
  • closure system has multiple elements that may emphasize possible tampering therewith, such as for example the bridges of the outer capsule or the bridges that connect the outer capsule to the tamper-evident ring.
  • closure system thus conceived is susceptible to many modifications and variants, all falling within the invention; moreover, all the details can be replaced by technically equivalent elements.
  • materials used, as well as their sizes, can be of any type according to the technical requirements.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a closure system (1) for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products, comprising:
- a perforable closure body (3) adapted to close the mouth (5) of a bottle (7);
- an inner capsule (9), able to be fitted onto the neck (11) of the bottle (7), configured to hold the closure body (3) in a sealed closure configuration of the mouth (5) of the bottle (7), in which the inner capsule (9) comprises an opening (13) adapted for allowing access to the closure body (3);
- an outer capsule (15), able to be fitted onto the inner capsule (9).
The peculiarity of the invention consists in the fact that the outer capsule (15) is made in a single body and comprises an upper disc-shaped portion (17) configured to close the opening (13) of the inner capsule (9) and a lower portion (19) able to be fitted around the inner capsule (9), in which the outer capsule (15) comprises a breaking line (21) between the upper disc-shaped portion (17) and the lower portion (19) .

Description

  • The present invention relates to a closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products.
  • Bottles or vials containing pharmaceutical products such as lyophilized or liquid products for injection or perfusion are generally closed by means of a perforable rubber plug, for example by means of a needle, held on the neck of the bottle by means of an aluminium capsule that completely covers the rubber plug. The aluminium capsules generally have a portion that may be removed by tearing, which allows access to the rubber plug.
  • The main drawback of aluminium capsules consists in the fact that the steps of mounting the capsule on the rubber plug and on the neck of the bottle cannot be executed in conditions of sterilisation and the absence of undesired particles because the folding and cutting operations of the aluminium sheets for making the capsules and the mounting thereof on the mouth of the bottle involve the generation of aluminium powders which are incompatible with the conditions of sterilisation and the absence of undesired particles required for the type of products contained in the bottle itself. Such aluminium capsules make it therefore difficult to minimise the level of particle contamination admitted into controlled-atmosphere environments, such as a cleanroom.
  • Another drawback of aluminium capsules consists in the fact that the operator who removes the removable portion risks being injured with the sharp edges of the aluminium sheet.
  • On the other hand, also the use of capsules made of materials of the plastic type are not free from drawbacks.
  • In particular, capsules made of plastic often are not capable of supporting the temperatures that can be reached in autoclave sterilisation processes, which may reach up to 140°C, or in any case they undergo deformations such as to put at risk the sterilisation conditions of the bottle itself. In order to resist the sterilisation processes, the plastic capsules must have more rigid structures that require a significant force of application in order to be mounted securely on the neck of the bottle, which force of application cannot generally be obtained with normal capsuling machines. The implementation of capsuling machines with increased force of application results in a significant increase of the set-up costs of the processing plant. Moreover, the use of an increased force could result in problems of the bottles or the capsules themselves breaking.
  • Plastic capsules are also known that have several and numerous components mutually assembled with one another in various operations which however, on the one hand do not ensure an adequate resistance to the autoclave sterilisation, and on the other hand, result in an apparent increase of the production and assembly times and costs of the capsule itself.
  • It is the object of the present invention to make a closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products, that is easier to make and mount on bottles, and therefore is more economically competitive when compared to the known technique, and in particular to the plastic capsule.
  • It is another object of the present invention to make a closure system for bottles that does not result in the formation of powder during the mounting on the bottles.
  • It is another object of the present invention to make a closure system that is capable of providing the amplest guarantees of reliability and safety in use.
  • It is another object of the present invention to make a closure system that allows the bottle to be subjected to autoclave sterilisation procedures.
  • These objects according to the present invention are achieved by making a closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products, as disclosed in claim 1.
  • Further features are provided in the dependent claims.
  • Further features and advantages shall be more apparent from the description of two preferred, but not exclusive, embodiments of a closure system for bottles, illustrated as an example and not for limiting purposes with reference to the accompanying drawings, in which:
    • figure 1 is a front view of a bottle provided with a first embodiment of a closure system, according to the invention;
    • figure 2 is a perspective view of the outer capsule of the closure system illustrated in figure 1, according to the invention;
    • figure 3 is a perspective view of the inner capsule of the closure system illustrated in figure 1;
    • figure 4 is a front sectional view of the closure system of figure 1, according to the invention;
    • figure 5 is a front sectional view of a variant of the closure system illustrated in figure 1, according to the invention;
    • figure 6 is a perspective view of a variant of the inner capsule of the closure system illustrated in figure 1 or in figure 7, according to the invention;
    • figure 7 is a front view of a bottle provided with a second embodiment of a closure system, according to the invention;
    • figure 8 is a perspective view of the outer capsule of the closure system illustrated in figure 7, according to the invention;
    • figure 9 is a front sectional view of the closure system of figure 7, according to the invention;
    • figure 10 is a front sectional view of a variant of the closure system illustrated in figure 7, according to the invention.
  • With reference to the mentioned drawings, the closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products, indicated as a whole with reference number 1, comprises:
    • a perforable closure body 3 adapted to close the mouth 5 of a bottle 7;
    • an inner capsule 9, able to be fitted onto the neck 11 of the bottle 7, configured to hold the closure body 3 in a sealed closure configuration of the mouth 5 of the bottle 7, in which the inner capsule 9 comprises an opening 13 adapted for allowing access to the closure body 3;
    • an outer capsule 15, able to be fitted onto the inner capsule 9.
  • According to the invention, the outer capsule 15 is made in a single body and comprises an upper disc-shaped portion 17 configured to close the opening 13 of the inner capsule 9 and a lower portion 19 able to be fitted around the inner capsule 9. Moreover, according to the invention, the outer capsule 15 comprises a breaking line 21 between the upper disc-shaped portion 17 and the lower portion 19.
  • As shown in the accompanying drawings, advantageously the outer capsule 15 closes and covers the inner capsule 9 both at the top and at the sides.
  • Advantageously, the inner capsule 9 comprises, on its lateral surface, a plurality of through-openings 33.
  • Advantageously, the lower portion 19 of the outer capsule 15 is fitted around the inner capsule 9, and preferably is fitted around the inner capsule 9 so as to completely cover the side thereof, and in particular the lateral through-openings 33.
  • Advantageously, the outer capsule 15 is fitted around the inner capsule 9 with interference so that the outer capsule 15 and the inner capsule 9 define a single body capable of giving resistance to the forces that develop, for example during the autoclave sterilisation.
  • Advantageously, the outer capsule 15 is made of a material of the plastic type through injection moulding.
  • Preferably, the outer capsule 15 is made of a material of the polypropylene type.
  • Advantageously, the breaking line 21 comprises a plurality of bridges 23 made through the aforesaid injection moulding.
  • In particular, the outer capsule 15 may be made in a single injection moulding step together also with the bridges 23.
  • Alternatively, or additionally, the breaking line 21 may comprise a weakened line defined by an incision, or partial cut, of the outer capsule 15 executed in a step successive to the one of the injection moulding of the outer capsule 15 itself.
  • The breaking line 21 allows easily separating the upper disc-shaped portion 17 of the outer capsule 15 from the lower portion 19 fitted around the inner capsule 9. This allows exposing the opening 13 of the inner capsule 9 and allows the access and perforation, for example by means of a needle, of the closure body 3.
  • The lower portion 19 of the outer capsule 15 may comprise, substantially at the breaking line 21, a band 25 having a radial thickness substantially less than the radial thickness of the remaining part of the lower portion 19.
  • Advantageously, as shown in the accompanying drawings, the lower portion 19 of the outer capsule 15 comprises, substantially at the breaking line 21, a band 25 having a radial thickness that narrows in the axial direction 27 of approach to the breaking line 21.
  • The reduction of the thickness of the wall of the outer capsule 15 at the breaking line 21 further facilitates the separation of the upper disc-shaped portion 17 from the lower portion 19.
  • In particular, the upper disc-shaped portion 17 may be raised upwards and pulled off from the lower portion 19 by acting with the fingertip on the lower perimeter edge 24 of the upper disc-shaped portion 17 itself, which edge 24 is exposed with respect to the lateral wall of the lower portion 19, due to the narrowing of the thickness thereof approaching the breaking line 21.
  • If the breaking line 21 were defined by a plurality of bridges 23, the rotation of the upper disc-shaped portion 17 with respect to the central axis 27 would produce the same separating effect of the upper disc-shaped portion 17 with respect to the lower portion 19 because it would cause the breaking of the bridges 23 themselves.
  • Advantageously, the inner capsule 9 comprises a plurality of elastically deformable tabs 29 projecting radially towards the inside of the inner capsule 9 itself. Such tabs 29 are configured to engage with the finish 31 of the bottle 7.
  • Advantageously, the tabs 29 are obtained at the through-openings 33 on the lateral surface of the inner capsule 9.
  • The tabs 29 are preferably equally distributed angularly around the central axis 27.
  • Advantageously, also the inner capsule 9 is made of a material of the plastic type, and preferably of the polycarbonate type, through injection moulding.
  • The through-openings 33 obtained at the tabs 29 allow facilitating the removal of the tabs 29 themselves from the injection mould.
  • Moreover, by engaging with the finish 31 of the bottle 7, the tabs 29 allow the inner capsule 9 to hold the closure body 3 in a sealed closure configuration against the mouth 5 of the bottle 7.
  • The fact that the tabs 29 are elastically deformable, also due to the presence of the through-openings 33, allows easily fitting the inner capsule 9 on the neck 11 of the bottle 7. Indeed, in step of pressure applying the inner capsule 9 onto the neck 11 of the bottle 7, the finish 31 exerts a force in horizontal direction on the tabs 29 themselves, which force deforms the tabs 29 radially outwards until they exceed the finish 31. Once they have exceeded the finish 31, the tabs 29 may return to their rest configuration projecting radially towards the inside of the inner capsule 9, in which configuration they engage at the bottom with the finish 31 of the bottle 7.
  • Advantageously, the portion of cylindrical wall 54 of the inner capsule 9 which lies at the bottom of the tabs 29 has an increased cross-section with respect to the cross-section of the overlying tabs 29. Thereby, the resistance is ensured to the forces which develop during the autoclave sterilisation.
  • Advantageously, the tabs 29 project radially towards the inside of the inner capsule 9 itself with an inclination which is less than or equal 30° with respect to the underlying portion of cylindrical wall 54, that is with respect to the vertical direction. Thereby, the resistance is further ensured to the forces which develop during the autoclave sterilisation. The closure body 3 may be a rubber gasket 30, as shown in figures 4 and 9, or a rubber plug 32 as shown in figures 5 and 10.
  • The rubber gasket 30 and the rubber plug 32 are advantageously held at the top against the mouth 5 of the bottle 7 by the inner capsule 9.
  • The rubber plug 32 also has a lower portion which is inserted, with interference, into the mouth 5 of the bottle 7.
  • Advantageously, the tabs 29 are adapted to hold the closure body 3 on the mouth 5 of the bottle 7, thus ensuring the seal of the liquid contained inside the bottle 7, also under the action of the internal pressure generated during the autoclave sterilisation treatment.
  • The lower portion 19 of the outer capsule 15 comprises at least one rib 35 projecting radially towards the inside of the outer capsule 15, configured to engage in a corresponding seat 37 obtained on the outer surface of the inner capsule 9.
  • Preferably, there are provided at least two ribs 35 and two corresponding seats 37.
  • Advantageously, the ribs 35 develop circumferentially around the whole lower portion 19 of the outer capsule 15, like the corresponding seats 37 develop circumferentially around the whole outer surface of the inner capsule 9.
  • Thereby, when the outer capsule 15 is fitted onto the inner capsule 9, the two components are firmly constrained to each other and define an assembly that can be handled as though it were a single body.
  • Advantageously, the inner capsule 9 may comprise a rib 45 projecting radially towards the inside of the capsule configured to hold, by interference, the closure body 3. Preferably, such rib 45 develops circumferentially around the whole inner capsule 9.
  • Due to the holding by interference of the closure body 3 by the inner capsule 9, the outer capsule 15, inner capsule 9 and closure body 3 assembly define an assembly that can be handled as though it were a single body.
  • As shown in figures 5 and 10, alternatively to the tabs 38, the disc-shaped upper portion 17 may comprise, at its face that faces the opening 13 of the inner capsule 9, a cylindrical wall 41 axially protruding towards the edge 39 of the opening 13 and configured to engage with such edge 39.
  • The cylindrical wall 41 ensures the centring of the disc-shaped upper portion 17 of the outer capsule 15 with respect to the edge 39 of the opening 13.
  • As shown instead in figures 4 and 9, the disc-shaped upper portion 17 of the outer capsule 15 may comprise, at its face facing the opening 13 of the inner capsule 9, a plurality of tabs 38 axially projecting towards the edge 39 of the opening 13 and configured to engage with such edge 39.
  • Advantageously, the tabs 38 are also folded around the edge 39 of the opening 13, for example in assembly step between the outer capsule 15 and the inner capsule 9.
  • The engagement of the tabs 38 of the outer capsule 15 with the edge 39 of the opening 13 of the inner capsule 9 further stabilizes the coupling between inner capsule 9 and outer capsule 15.
  • In particular, such coupling provides the upper disc-shaped portion 17 with increased resistance to the internal pressure that is generated in vertical direction in the bottle 7, and therefore increased resistance to the push that acts on the closure body 3 during the autoclave sterilisation treatment.
  • The presence of the tabs 38 or of the cylindrical wall 41 does not however prevent the separation of the upper disc-shaped portion 17 of the outer capsule 15 from the lower portion 19 because such tabs 38, or such cylindrical wall 41, are removed from the edge 39 of the opening 13 when the upper disc-shaped portion 17 of the outer capsule 15 is removed.
  • In the variant of inner capsule 9 illustrated in figure 6, there are advantageously provided a plurality of bodies 47 projecting axially and radially towards the inside of the capsule 9, which are configured to hold the closure body 3 in the inner capsule 9.
  • In the embodiment illustrated in figures 7 to 10, the closure system 1 comprises a tamper-evident ring 43 associated with the outer capsule 15. The tamper-evident ring 43 is advantageously associated with the lower edge of the outer capsule 15 by means of a plurality of bridges 49.
  • The tamper-evident ring 43 comprises advantageously an undercut 51 configured to engage with the lower edge 53 of the inner capsule 9.
  • The tamper-evident ring 43 serves the purposes of emphasizing any attempts to tamper with the closure system 1.
  • When the bottle 7 is used, the operator, or patient, lifts the edge 24 of the upper disc-shaped portion 17 of the outer capsule 15 with his/her fingertip, thus breaking any bridges 23 that join such upper portion to the lower portion 19 and removing the tabs 38, or the circular wall 41, from the edge 39 of the opening 13 of the inner capsule 9.
  • Thereby, the opening 13 of the inner capsule 9 is exposed and it is possible to perforate the closure body 3 with a needle at the opening 13 of the inner capsule 9 to introduce it into the mouth 5 of the bottle 7 in order to suck the liquid contained in the bottle 7.
  • The closure system object of the present invention has the advantage of being made completely of a material of the plastic type and of being pressure applied onto the bottles, without generating powders that are incompatible with the sterility requirements of the product contained in the bottle itself, as instead happens in the case of closure systems at least partially made of aluminium.
  • Another advantage of the invention consists in the fact that the outer capsule, inner capsule and closure body assembly may be applied as though they were a single body, in a single step, to the bottle, directly in the cleanroom, immediately after the filling of the bottle with the product required. The application of the aforesaid assembly may also be executed in completely automated manner.
  • Another advantage again of the invention consists in the fact that the tabs on the inner capsule on the one hand, allow the closure system to resist in a satisfactory manner to the stresses generated during the autoclave sterilisation process, and on the other hand, to be easily pressure applied to the neck of the bottle.
  • A further advantage of the closure system according to the invention consists in the fact of being made in a minimum number of pieces that are easy to assemble with one another, that is rubber outer capsule, inner capsule and closure body.
  • The fact that the number of separate components of the closure system is minimised makes both the production of the closure system and its assembly on the bottle more economical and quicker.
  • Another advantage again of the invention consists in the fact that the closure system has multiple elements that may emphasize possible tampering therewith, such as for example the bridges of the outer capsule or the bridges that connect the outer capsule to the tamper-evident ring.
  • The closure system thus conceived is susceptible to many modifications and variants, all falling within the invention; moreover, all the details can be replaced by technically equivalent elements. In practice, the materials used, as well as their sizes, can be of any type according to the technical requirements.

Claims (11)

  1. Closure system (1) for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products, comprising:
    - a perforable closure body (3) adapted for closing the mouth (5) of a bottle (7);
    - an inner capsule (9), able to be fitted onto the neck (11) of said bottle (7), configured to hold said closure body (3) in a sealed closure configuration of said mouth (5) of said bottle (7), said inner capsule (9) comprising an opening (13) adapted for allowing access to said closure body (3);
    - an outer capsule (15), able to be fitted onto said inner capsule (9);
    characterised in that said outer capsule (15) is made in a single body and comprises an upper disc-shaped portion (17) configured to close said opening (13) of said inner capsule (9) and a lower portion (19) able to be fitted around said inner capsule (9), said outer capsule (15) comprising a breaking line (21) between said upper disc-shaped portion (17) and said lower portion (19).
  2. Closure system (1), according to claim 1, characterised in that said outer capsule (15) is made of a material of the plastic type through injection moulding.
  3. Closure system (1), according to claim 1 or 2, characterised in that said breaking line (21) comprises a plurality of bridges (23) made through said injection moulding.
  4. Closure system (1), according to claim 1 or 2, characterised in that said breaking line (21) comprises a weakened line made through incision following said injection moulding.
  5. Closure system (1), according to one or more of the previous claims, characterised in that said lower portion (19) of said outer capsule (15) comprises, substantially at said breaking line (21), a band (25) having a radial thickness substantially less than the radial thickness of the remaining part of said lower portion (19).
  6. Closure system (1), according to one or more of the previous claims, characterised in that said lower portion (19) of said outer capsule (15) comprises, substantially at said breaking line (21), a band (25) having a radial thickness that narrows in the axial direction (27) of approach to said breaking line (21).
  7. Closure system (1), according to one or more of the previous claims, characterised in that said inner capsule (9) comprises a plurality of elastically deformable tabs (29) projecting radially towards the inside of said inner capsule (9), said tabs (29) being configured to engage with the bottle finish (31) of said bottle (7), said tabs (29) being obtained at through-openings (33) present on the lateral surface of said inner capsule (9).
  8. Closure system (1), according to one or more of the previous claims, characterised in that said lower portion (19) of said outer capsule (15) comprises at least one rib (35) projecting radially towards the inside of said outer capsule (15) configured to engage in a corresponding seat (37) obtained on the outer surface of said inner capsule (9).
  9. Closure system (1), according to one or more of the previous claims, characterised in that said disc-shaped upper portion (17) comprises, at its face that faces said opening (13) of said inner capsule (9), a cylindrical wall (41) projecting axially towards the edge (39) of said opening (13) and configured to engage with said edge (39).
  10. Closure system (1), according to one or more of the previous claims, characterised in that said disc-shaped upper portion (17) comprises, at its face that faces said opening (13) of said inner capsule (9), a plurality of tabs (38) projecting axially towards the edge (39) of said opening (13) and configured to engage with said edge (39) and folded around said edge (39) of said opening (13).
  11. Closure system (1), according to one or more of the previous claims, characterised in that a tamper-evident ring (43) is associated with said outer capsule (15).
EP17194211.3A 2016-11-24 2017-09-29 Closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products Active EP3326932B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000119044A IT201600119044A1 (en) 2016-11-24 2016-11-24 CLOSING SYSTEM FOR BOTTLES CONTAINING LIOFILIZED OR LIQUID PRODUCTS, PARTICULARLY INJECTABLE OR PERFUSIONAL PHARMACEUTICAL PRODUCTS.

Publications (2)

Publication Number Publication Date
EP3326932A1 true EP3326932A1 (en) 2018-05-30
EP3326932B1 EP3326932B1 (en) 2019-09-11

Family

ID=58401973

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17194211.3A Active EP3326932B1 (en) 2016-11-24 2017-09-29 Closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products

Country Status (3)

Country Link
EP (1) EP3326932B1 (en)
ES (1) ES2761354T3 (en)
IT (1) IT201600119044A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021016328A1 (en) * 2019-07-23 2021-01-28 West Pharmaceutical Services, Inc. Vial closure assembly
WO2021144511A1 (en) * 2020-01-16 2021-07-22 A. Raymond Et Cie Locking cover for a container having a neck, with a cap having breakable securing tabs
EP4085892A1 (en) 2021-05-06 2022-11-09 KAISHA PACKAGING Private Ltd. Tamper evident plastic closure for vials for storing substances for medical or pharmaceutical applications and use thereof
USD1006621S1 (en) 2021-06-11 2023-12-05 KAISHA PACKAGING Private Ltd. Tamper evident plastic closure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080245A (en) * 1990-03-22 1992-01-14 The West Company Incorporated Bidirectional scoring
WO1997031839A1 (en) * 1996-02-29 1997-09-04 Bormioli Rocco & Figlio S.P.A. A capsule for security closure of containers
WO2011039004A1 (en) * 2009-10-01 2011-04-07 A. Raymond Et Cie Locking cover for a vessel having a neck, including a cap having attachment tabs
US20130245592A1 (en) * 2012-03-16 2013-09-19 Fisher Scientific Company L.L.C. Chlorobutyl rubber-based self-resealing septum and closure assembly

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080245A (en) * 1990-03-22 1992-01-14 The West Company Incorporated Bidirectional scoring
WO1997031839A1 (en) * 1996-02-29 1997-09-04 Bormioli Rocco & Figlio S.P.A. A capsule for security closure of containers
WO2011039004A1 (en) * 2009-10-01 2011-04-07 A. Raymond Et Cie Locking cover for a vessel having a neck, including a cap having attachment tabs
US20130245592A1 (en) * 2012-03-16 2013-09-19 Fisher Scientific Company L.L.C. Chlorobutyl rubber-based self-resealing septum and closure assembly

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021016328A1 (en) * 2019-07-23 2021-01-28 West Pharmaceutical Services, Inc. Vial closure assembly
CN114206746A (en) * 2019-07-23 2022-03-18 西医药服务有限公司 Vial closure assembly
US12071279B2 (en) 2019-07-23 2024-08-27 West Pharmaceutical Services, Inc. Vial closure assembly
WO2021144511A1 (en) * 2020-01-16 2021-07-22 A. Raymond Et Cie Locking cover for a container having a neck, with a cap having breakable securing tabs
FR3106339A1 (en) * 2020-01-16 2021-07-23 A. Raymond Et Cie Locking cap for collared container with a capsule with securing tabs
EP4085892A1 (en) 2021-05-06 2022-11-09 KAISHA PACKAGING Private Ltd. Tamper evident plastic closure for vials for storing substances for medical or pharmaceutical applications and use thereof
US11850210B2 (en) 2021-05-06 2023-12-26 Kaisha Packaging Private Limited Tamper evident plastic closure for vials for storing substances for medical or pharmaceutical applications and use thereof
USD1006621S1 (en) 2021-06-11 2023-12-05 KAISHA PACKAGING Private Ltd. Tamper evident plastic closure

Also Published As

Publication number Publication date
EP3326932B1 (en) 2019-09-11
ES2761354T3 (en) 2020-05-19
IT201600119044A1 (en) 2018-05-24

Similar Documents

Publication Publication Date Title
EP3326932B1 (en) Closure system for bottles containing lyophilized or liquid products, particularly injectable or perfusable pharmaceutical products
EP3313747B1 (en) Closing assembly for a bottle, associated bottle and assembly method
US3393817A (en) Sealed feeding bottle assembly
JP6309890B2 (en) Closing device and container having the device
EP3042862B1 (en) Cap for vial
US5269429A (en) Closure cap for infusion or transfusion bottles
EP0634340B1 (en) Bottle for preserving in a separated condition substance to be mixed together before dispensing
MX2014009127A (en) Locking device for a cap.
SE450567B (en) CONTAINER CLOSURE
CA2931014A1 (en) Closure assembly for bottle and assembly method
GB1580306A (en) Airtight container
EP3615447B1 (en) Safety capsule with strip for preventing extraction
AU2018390412A1 (en) Lid for containers under vacuum
US9265696B2 (en) Closure cap
RU2461500C2 (en) Container and method of its fabrication
EP4296187A1 (en) Closure device, particularly for bottles of lyophilized products, and process for closing a bottle of lyophilized products
CN112638347A (en) Device for temporarily connecting two containers
IE41596B1 (en) Over cap
AU2015341110B2 (en) Container comprising a single-piece head section
JP5083851B1 (en) Pilfer proof cap with TE cover
EP3296224B1 (en) A cap and neck assembly for a food package
JP6429594B2 (en) Container with tamper-evident prevention mechanism
KR20100004811U (en) Cosmetic vessel with an airtight sealed structure
WO2001083314A1 (en) Bottle and closure assembly for medicaments and phleboclysis
WO2022172101A1 (en) Bottle for a container for parenterally administrable pharmaceutical products

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RIZZARDI, MARCO MARIA CARLO

Inventor name: ADDABBO, GIUSEPPE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181114

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20190405

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1178174

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190915

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017006922

Country of ref document: DE

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20190911

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191212

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1178174

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200113

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2761354

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20200519

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200224

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017006922

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG2D Information on lapse in contracting state deleted

Ref country code: IS

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190929

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190929

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200112

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190930

26N No opposition filed

Effective date: 20200615

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190930

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20170929

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190911

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210929

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230518

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230911

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231006

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240806

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240808

Year of fee payment: 8